Visco, A. G., Brubaker, L., Richter, H. E., Nygaard, I., Paraiso, M. F. R., Menefee, S. A., … Meikle, S. F. (2013). Anticholinergic therapy vs. OnabotulinumtoxinA for urgency urinary incontinence. Obstetrical and Gynecological Survey, 68(2), 102–104. https://doi.org/10.1097/01.ogx.0000427620.34769.ed

Visco, A. G., L. Brubaker, H. E. Richter, I. Nygaard, M. F. R. Paraiso, S. A. Menefee, J. Schaffer, et al. “Anticholinergic therapy vs. OnabotulinumtoxinA for urgency urinary incontinence.” Obstetrical and Gynecological Survey 68, no. 2 (February 1, 2013): 102–4. https://doi.org/10.1097/01.ogx.0000427620.34769.ed.

Visco AG, Brubaker L, Richter HE, Nygaard I, Paraiso MFR, Menefee SA, et al. Anticholinergic therapy vs. OnabotulinumtoxinA for urgency urinary incontinence. Obstetrical and Gynecological Survey. 2013 Feb 1;68(2):102–4.

Visco, A. G., et al. “Anticholinergic therapy vs. OnabotulinumtoxinA for urgency urinary incontinence.” Obstetrical and Gynecological Survey, vol. 68, no. 2, Feb. 2013, pp. 102–04. Scopus, doi:10.1097/01.ogx.0000427620.34769.ed.

Visco AG, Brubaker L, Richter HE, Nygaard I, Paraiso MFR, Menefee SA, Schaffer J, Lowder J, Khandwala S, Sirls L, Spino C, Nolen TL, Wallace D, Meikle SF. Anticholinergic therapy vs. OnabotulinumtoxinA for urgency urinary incontinence. Obstetrical and Gynecological Survey. 2013 Feb 1;68(2):102–104.